ARIAGEN, INC.
8Patents
8Active
8Granted
47Portfolio score
Filing activity: Sep 10, 2015 → Aug 15, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10081610B2 | Efficient and scalable synthesis of 2-(1′h-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester and its structural analogs | Chemistry; Metallurgy | 1 | Active |
| US11390621B2 | Chiral indole compounds and their use | Human Necessities | 1 | Active |
| US11547698B2 | Aryl hydrocarbon receptor modulators | Chemistry; Metallurgy | 1 | Active |
| US11427576B2 | Indole compounds and their use | Chemistry; Metallurgy | 1 | Active |
| US11459322B2 | Indole compounds and their use | Chemistry; Metallurgy | 1 | Active |
| US10632106B2 | Methods of cancer treatment with 2-(1′H-Indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester | Chemistry; Metallurgy | 0 | Active |
| US11891386B2 | Indole compounds and their use | Chemistry; Metallurgy | 0 | Active |
| US10195182B2 | ITE for cancer intervention and eradication | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.